HAE — Haemonetics Corporation

Stock analysis, AI verdict, fundamentals & technical signals

Rating: HOLD

Price: $120.28 Analyst target: $124.50 Upside: 3.51%

About Haemonetics Corporation

Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.

See the full interactive analysis & chart →

Informational only — not investment advice.